April 2020: an ambulance picks up a possible covid patient near Liège. Whether the pill really makes a difference – and thus reduces the risk of hospitalization – will be known in September or October. — © afp
The drug company Merck is investigating whether molnupiravir can prevent the first symptoms from derailing into severe covid-19. It is one of the few drugs in the pipeline to avoid hospital admissions.
Read Also
- In Ukraine officially kicked off IFA-antibody testing COVID-19 May 21, 2020
- Mallorca leads another uptick in Covid case numbers in the Balearics Jul 20, 2021
- Editorial The pandemic taught colleges new ways Aug 22, 2021
- 19 surgeries are suspended at the Regional Hospital during the first day of the Fenats stoppage Nov 9, 2022
- Brazil, the early treatments recommended by the CFM attacked by scientific organizations! Apr 19, 2021
- Covid, virologist Menichetti: “Caution on vaccine at under 12” Jul 28, 2021
- Pyrénées-Orientales: A virtual place dedicated to diabetics created in the metaverse by the Perpignan hospital Nov 15, 2022
Maxie Eckert
Today at 11:34 AM
.
